GeneDx Bryan Dechairo

GeneDx has named Bryan Dechairo as its inaugural chief operating officer, overseeing the company's products and technology, operations, medical affairs, innovation, and program management teams. Before joining GeneDx, Dechairo served as the president and CEO of Sherlock Biosciences. He also held executive leadership roles at several diagnostic and pharmaceutical companies, including Pfizer and Myriad Genetics. Dechairo holds a PhD in human genetics from the University College of London and a BA in integrative biology from the University of California, Berkeley.